Demographic and Asthma-Related Characteristics of Asthmatics Using Pressurized Metered Dose Inhalers and Dry Powder Inhalers
Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2024
DOI: 10.1089/jamp.2024.0006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2024. Verfasst von Kurtuluş Aksu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, Department of Chest Diseases, University of Health Sciences Atatürk Sanatoryum Training and Research Hospital, An…. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Asthma, Medication Adherence, Metered Dose Inhalers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Asthma controller medications can be delivered via pressurized metered dose inhaler (pMDI) or dry powder inhaler (DPI) devices.
Objective
This study aimed to evaluate the frequency of exacerbations and satisfaction rate with device use in asthmatics using pMDIs or DPIs.
Methods
A multicenter, cross-sectional study was conducted in adults who used pMDIs or DPIs with correct inhaler technique and good adherence for asthma treatment. Demographic and asthma-related characteristics of the subjects and data regarding device satisfaction were collected through a face-to-face interview in the outpatient clinic. Rates of pMDI and DPI users and the data were compared between the two groups.
Results
The study included 338 patients (mean age: 48.6 ± 14.5 years, 253 [74.9%] women). Among participants, 96 (28.4%) were using pMDI and 242 (71.6%) were using DPI. The age of patients using pMDI were significantly lower compared with DPI users. No significant difference was observed in terms of device satisfaction and clinical outcomes of asthma between pMDI and DPI users with good inhaler technique and good adherence.
Conclusion
More asthmatics use DPIs, however, pMDIs are used in younger asthmatic patients. No significant difference in terms of device satisfaction and clinical outcomes of asthma was observed between pMDI and DPI users.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Immunology and Allergy, Department of Chest Diseases, University of Health Sciences Atatürk Sanatoryum Training and Research Hospital, Ankara, Turkey.
- Department of Chest Diseases, Tekirdağ Namık Kemal University Faculty of Medicine, Tekirdağ, Turkey.
- Faculty of Medicine, Department of Chest Diseases, Çanakkale 18 Mart University, Çanakkale, Turkey.
- Department of Chest Diseases, Mardin Training and Research Hospital, Mardin, Turkey.
- Department of Chest Diseases, Ankara Etlik City Hospital, Ankara, Turkey.
- Department of Chest Diseases, Selçuk University Faculty of Medicine, Konya, Turkey.
ORCID-Profile: Kurtuluş Aksu
Zitieren
APA
Aksu, K., Vural Solak, G. T., Mutlu, L. C., Mutlu, P., Vayısoğlu Şahin, G., Erdem Türe, E., Yormaz, B., Çapraz, A., Coşkun Beyan, A., Solak, Y., & Aksu, F. (2024). Demographic and Asthma-Related Characteristics of Asthmatics Using Pressurized Metered Dose Inhalers and Dry Powder Inhalers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. https://doi.org/10.1089/jamp.2024.0006
Vancouver
Aksu K, Vural Solak GT, Mutlu LC, Mutlu P, Vayısoğlu Şahin G, Erdem Türe E, et al. Demographic and Asthma-Related Characteristics of Asthmatics Using Pressurized Metered Dose Inhalers and Dry Powder Inhalers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2024. doi:10.1089/jamp.2024.0006
BibTeX
@article{Aksu2024,
author = {Aksu, Kurtuluş and Vural Solak, Gürgün Tuğçe and Mutlu, Levent Cem and Mutlu, Pınar and Vayısoğlu Şahin, Görkem and Erdem Türe, Ezgi and Yormaz, Burcu and Çapraz, Aylin and Coşkun Beyan, Ayşe and Solak, Yavuzalp and Aksu, Funda},
title = {Demographic and Asthma-Related Characteristics of Asthmatics Using Pressurized Metered Dose Inhalers and Dry Powder Inhalers},
journal = {Journal of Aerosol Medicine and Pulmonary Drug Delivery},
year = {2024},
doi = {10.1089/jamp.2024.0006}
}
EUVIMED